Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 120486
Published online Aug 15, 2026. doi: 10.4251/wjgo.120486
Published online Aug 15, 2026. doi: 10.4251/wjgo.120486
Table 2 Comparison of pain-related indicators between the two groups of patients before and after intervention, mean ± SD
| Index | Group | Before intervention | After intervention | t | P value |
| NRS score (points) | Observation group (n = 50) | 6.8 ± 1.2 | 2.3 ± 0.8 | 6.92 | < 0.001 |
| Control group (n = 50) | 6.7 ± 1.3 | 3.7 ± 1.0 | |||
| Number of pain attacks per day | Observation group (n = 50) | 2.8 ± 0.9 | 0.4 ± 0.3 | 12.15 | < 0.001 |
| Control group (n = 50) | 2.7 ± 1.0 | 1.5 ± 0.6 | |||
| Average daily dose of opioids (mg OME) | Observation group (n = 50) | 185.3 ± 30.5 | 85.6 ± 20.3 | 10.38 | < 0.001 |
| Control group (n = 50) | 182.7 ± 29.8 | 132.4 ± 25.6 |
- Citation: Wang XY, Wang ZD, Kan K, Guo XX. Impact of combined pregabalin and multimodal analgesia on cancer pain and quality of life in advanced colorectal cancer. World J Gastrointest Oncol 2026; 18(8): 120486
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/120486.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120486